Removing the cells from adult bone marrow derived stem cell therapy does not eliminate cardioprotection† | Zendy

Mohammed Yasin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Removing the cells from adult bone marrow derived stem cell therapy does not eliminate cardioprotection†

Author(s) -

Mohammed Yasin

Publication year - 2012

Publication title -

european journal of cardio-thoracic surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.303

H-Index - 133

eISSN - 1873-734X

pISSN - 1010-7940

DOI - 10.1093/ejcts/ezs409

Subject(s) - bone marrow , medicine , cd34 , stem cell , haematopoiesis , cardioprotection , myocardial infarction , hematopoietic stem cell , bone marrow stem cell , cardiology , andrology , biology , microbiology and biotechnology

The debate as to whether adult stem cell therapy is regenerative or not continues. The non-regenerative benefits of adult bone marrow-derived stem cell therapy were investigated by testing whether the supernatant derived from unfractionated bone marrow mononuclear cells might be cardioprotective in an animal model of myocardial ischaemia-reperfusion injury.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research